Ulcerations due to methotrexate toxicity in a psoriasis patient
- PMID: 27438211
- PMCID: PMC4938288
- DOI: 10.1590/abd1806-4841.20163960
Ulcerations due to methotrexate toxicity in a psoriasis patient
Abstract
Methotrexate is one of the most used drugs in the treatment of psoriasis with indication of systemic therapy. Cutaneous and mucous side effects are described by pharmacological characteristics of the drug itself or due to overdose. We report the case of a patient with ulcerations in oral mucosa and psoriatic plaques after incorrect use of Methotrexate. Prescribed in a weekly dose, it was used continuously for 10 days and without simultaneous intake of folic acid. It is important to ensure correct comprehension of the prescription.
Conflict of interest statement
Conflict of Interest: None.
Figures
References
-
- Alencar M, Avelleira JC. Consenso Brasileiro de Psoríase 2012: guias de avaliação e tratamento Sociedade Brasileira de Dermatologia. 2 ed. Rio de Janeiro: Sociedade Brasileira de Dermatologia; 2012. Metotrexate; p. 67p.
-
- Ataíde DST, Esmanhoto LDK, Helmer KA, Guerra IRC, Guimarãesn CCG, Moritz S. Ulceração das placas psoriáticas - efeito adverso do metotrexate em altas doses no tratamento da psoríase: relato de três casos. An Bras Dermatol. 2003;78:749–753.
-
- Kerstens PJ, Boerbooms AM, Jeurissen ME, Fast JH, Assmann KJ, van de Putte LB. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases. J Rheumatol. 1992;19:867–871. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources